China Healthcare Reform: the “Two Invoice System”
The European Chamber is delighted to welcome Yvonne Wu, Lead Partner, China Life Sciences and Healthcare, Deloitte, and Bill Ye, Partner, King & Wood Mallesons to discuss the impact of this purchasing reform on multinational pharmaceutical companies and other related industries. In addition to outlining how the new process will work in practice, this seminar will highlight the measures European companies need to be taking to ensure they are ready to comply with this major new policy update.